CBD Creams, Balms and Lotions: Claims and Evidence

The short answer

Creams, balms and lotions are the most common way people use CBD (cannabidiol) on the skin. The honest summary is that human trials are few, small and mixed, and results from swallowed CBD products cannot be assumed to apply to skin products. This page does not advise anyone to use or avoid a product. It explains what has been studied. Evidence labels used here: promising but limited, mixed, insufficient evidence, preclinical (cells/animals only) and marketing claim.

Creams, balms and lotions: what the words mean

These names describe texture and base, not strength or quality. A lotion is usually thinner and water-based; a cream is thicker; a balm or salve is typically oil- or wax-based. None of the terms tells you how much CBD is in the product, whether other cannabinoids are present, or how much reaches the skin. For label vocabulary, see CBD products: forms and labels and full-spectrum, broad-spectrum and isolate CBD.

What human trials show

A systematic review of skin-applied CBD trials found only eight of 544 articles met its criteria: three placebo-controlled randomized trials and five single-arm trials. Risk of bias was high, the formulations differed, and the authors warned that users risk generalizing poorly designed trials to all CBD preparations. [1]

Taken together the label is mixed. The positive trials were tiny and each tested a different product, and the review above judged the field's evidence too weak to draw firm conclusions. [1]

Animal and cell findings are not human results

A review of topical or peripherally applied cannabinoids for pain found 46 studies (6 human, 40 animal). Animal studies pointed toward pain-blunting effects, but the authors rated that evidence low quality and said good human trials were scarce. [7] That is preclinical evidence for most claims. It does not show that a cream relieves pain in people.

Does the skin absorb it?

Skin is a tough barrier and cannabinoids dissolve in oils, so getting them through is hard. A review of delivery research described the number of detailed clinical trials on cannabinoid skin delivery as limited. [8] How deep any one product goes depends on its whole recipe, which is rarely disclosed. See topical vs transdermal products for the difference between acting at the skin and entering the bloodstream.

Skin conditions

A 2025 meta-analysis of cannabinoid skin treatments (topical cannabis extract ointment, CBD and others; 3,359 participants) found a modest reduction in itch, with no significant effect on dryness, redness or quality of life in atopic dermatitis. [9] Narrative reviews describe preclinical findings for acne, psoriasis and eczema but say confirmed clinical efficacy is still lacking. [10]

Rules and claims in the US

The FDA says cosmetics do not need premarket approval, but a product intended to treat disease or affect the body's structure or function is a drug. The agency says Epidiolex is the only FDA-approved drug containing CBD and that it has sent warning letters to firms selling CBD products with therapeutic claims. [11] A cream described as treating pain or arthritis is making a medical claim; label that marketing claim unless an approved medicine is involved. Laws elsewhere differ and change; this is not legal advice. See food and cosmetic rules for cannabinoids.

Safety

Adverse events in the trials above were uncommon and mild or absent, but the systematic review noted that such data mean little when efficacy is unproven. [1] Other ingredients in a product can also affect skin; see topical product safety. Do not apply products to broken skin without asking a clinician. If you take prescription medicines, are pregnant or breastfeeding, talk with a clinician or pharmacist first; see CBD and medication interactions. Adverse reactions to a cosmetic can be reported to the FDA's MedWatch (1-800-FDA-1088). [11]